Cognitive Functioning Among De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression

被引:0
|
作者
Buerker, B. S. [1 ]
Andersson, S. [1 ]
Gullestad, L. [2 ]
Gude, E. [2 ]
Relbo, A. [2 ]
Grov, I. [2 ]
Malt, U. F. [3 ]
Andreassen, A. K. [2 ]
Fiane, A. E. [4 ]
Haraldsen, I. H. [1 ]
机构
[1] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Psychosomat Med, N-0027 Oslo, Norway
[2] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway
[3] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Res & Educ, N-0027 Oslo, Norway
[4] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Thorac Surg, N-0027 Oslo, Norway
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
645
引用
收藏
页码:S239 / S239
页数:1
相关论文
共 50 条
  • [31] Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency
    Wujcik, K.
    Barkoff, L.
    Lee, J.
    Hollander, S. A.
    Chen, C.
    Gonzales, S.
    Profita, E.
    Almond, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S623 - S624
  • [32] A Low incidence of CMV Infections in De Novo Cardiac Transplant Recipients in the Presence of Everolimus-Based Immunosuppressive Regimens
    Kobashigawa, J.
    Eisen, H. J.
    Valantine-von Kaeppeler, H. A.
    Dengler, T.
    Potena, L.
    Wang, S. -S.
    Ross, H.
    Delgado, J.
    Starling, R. C.
    Bara, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S170 - S171
  • [33] Renal Preservation with Belatacept-Based versus Everolimus-Based Immunosuppression in Lung Transplant Recipients
    Sartain, E.
    Schoeppler, K.
    Crowther, B.
    Smith, J.
    Gray, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 383 - 383
  • [34] Low rate of CMV infection across everolimus-based regimens in de novo heart transplant patients
    Bara, Cristoph
    Valantine-von Kaeppeler, Hannah A.
    Dengler, Thomas
    Branzi, Angelo
    Wang, Shoei-Sheng
    Ross, Heather
    Delgado, Juan
    Starling, Randall C.
    Eisen, Howard J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 184 - 185
  • [35] CARDIOVASCULAR EVENTS WITH DE NOVO USE OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS
    Potena, Luciano
    Schulz, Uwe
    Bara, Christoph
    Arizon Del Prado, Jose M.
    Balfour, Alison
    Kohler, Sven
    Lopez, Patricia M.
    Epailly, Eric
    TRANSPLANT INTERNATIONAL, 2013, 26 : 46 - 46
  • [36] EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Prokopenko, E. I.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (02): : 74 - 81
  • [37] Utility of immune monitoring in heart transplant recipients on everolimus-based immune suppression
    Ben Gal, Tuvia
    Israeli, Moshe
    Yaari, Victoria
    Hasdai, David
    Matz, Israel
    Yussim, Alexander
    Battler, Alexander
    Klein, Tirza
    Medalion, Benjamin
    CLINICAL TRANSPLANTATION, 2014, 28 (04) : 428 - 433
  • [38] Early vs. Delayed EVERolimus in De Novo HEART Transplant Recipients
    Potena, L.
    Rinaldi, M.
    Maiello, C.
    Livi, U.
    Gerosa, G.
    Faggian, G.
    Pellegrini, C.
    Musumeci, F.
    Frigerio, M.
    Marraudino, N.
    Porcu, M.
    Veneziano, A.
    Maccherini, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S35 - S35
  • [39] IMPACT OF EVEROLIMUS ON PERICARDIAL AND PLEURAL EFFUSIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS
    Barten, M.
    Zuckermann, A.
    Arizon, J. M.
    Dong, G.
    Eisen, H.
    Kobashigawa, J.
    Lehmkuhl, H. B.
    Pellegrini, C.
    Ross, H.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 8 - 8
  • [40] Renal Recovery After Conversion to an Everolimus-Based Immunosuppression in Early and Late Heart Transplant Recipients: A 12-Month Analysis
    Michel, Sebastian
    Bigdeli, Amir Khosrow
    Hagl, Christian
    Meiser, Bruno
    Kaczmarek, Ingo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (05) : 429 - 434